Newsletter | August 4, 2025

08.04.25 -- From Protocol To People: Teva's Patient-First Clinical Trials Approach

SPONSOR

The PDA Pharmaceutical Microbiology Conference 2025 marks two decades of advancing microbiological science and practice. This milestone event brings together the global microbiology community, including experts from industry, academia, and regulatory agencies, to explore the evolving landscape of pharmaceutical microbiology. This year’s theme, Microbial Resilience: Today’s Response, Tomorrow’s Plan, reflects our focus on navigating present-day challenges while building robust strategies for the future.

PATIENT RECRUITMENT

No Stipends, But You Will See A Doctor

In Mexico, Bridget Ristagno explains you can’t offer stipends for clinical trial participants. But, what is even more appealing to them is the fact that they can have access to a physician.

Improving The Patient Experience In Clinical Research

To preserve the quality of care and build a more effective approach to trial design, a sponsor must consider their approach to patient recruitment and enrollment early and often.

The Evolution Of Caregivers In Research

With the increase of the sandwich generation of caregivers come new challenges and opportunities for clinical trial participation.

Streamline Recruitment With Confidence

Transform your clinical trial recruitment with a service that delivers faster, more cost-effective enrollment, particularly for hard-to-reach populations.

Streamlining Phase 1 Trials With The Mobile Vision Pod

A contract research organization formed a partnership to address significant challenges during a Phase 1 clinical trial for a corneal disease treatment through the use of a Mobile Vision Pod.

CLINICAL SITES

Paving The Way For Sites To Use Their Own Tech

The DTRA has released a detailed playbook to help clinical research sites use their own validated technology in sponsor-led trials. The "Bring Your Own Technology" (BYOT) model aims to reduce tech overload at sites, improve efficiency, and preserve regulatory compliance — starting with eConsent as its first use case.

What Sites Really Want: Insights From The 2024 Site Landscape Survey

Take a closer look at the 2024 SCRS Site Landscape Survey—and what sites say they need most. Less friction. More follow-through. And partners who actually lighten the load.

PATIENT CENTRICITY

From Protocol To People: Teva's Patient-First Clinical Trials Approach

Teva Pharmaceuticals' Head of Global Early Clinical Development shares how the company approaches drug development by getting patient input early and often.

A Deep Dive Into Clinical Trial Payment Types, Methods, And Amounts

Explore key themes surrounding payments to clinical research participants in depth, with a particular focus on the role of participant compensation and best practices in payment logistics.

Effective Engagement Strategies With Patient Advocacy Organizations

Collaboration between drug development companies and Patient Advocacy Organizations is essential to bridging gaps between stakeholders and advancing rare disease research.

Ensure The Management Of Patient Inquiries Reflects Your Brand Values

Bridge the gap between patients and study teams by delivering a patient-centered inquiry management solution that aligns with institutional brand values and enhances access to clinical trials.

CHOOSE YOUR OWN ADVENTURE

You're receiving the Monday edition of the Clinical Leader newsletter, focusing on Clinical SitesPatient Centricity, and Patient Recruitment. To make changes to your newsletter selections, update your topic preferences.

  • Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
  • Clinical Trial Technology (Tuesday)
  • Decentralized Trials | Trial Management (Wednesday)
  • Outsourcing Models | Regulatory & Compliance (Thursday)
  • Clinical Data Management & Analytics | Trial Monitoring (Friday)

Learn more about our personalized newsletters here.

Connect With Clinical Leader: